| ACN | acute conditioned neurosis; Ambulatory Care Network; American College of Neuropsychiatrists; America... |
|---|---|
| AIN | acute interstitial nephritis; American Institute of Nutrition; anterior interosseous nerve |
| AMRNL | Army Medical Research and Nutrition Laboratory |
| ANS | acanthion; American Nutrition Society; 8-anilino-1-naphthalene-sulfonic acid; anterior nasal spine; ... |
| ASPEN | American Society for Parenteral and Enteral Nutrition |
| INCAP | Institute of Nutrition of Central America and Panama |
|---|---|
| IDPN | Intradialytic parenteral nutrition |
| NHANES | National Health and Nutrition Examination Survey |
| NHANES I | National Health and Nutrition Examination Survey |
| NHANES II | National Health and Nutrition Examination Survey |
| biological assessment | A specific process required as part of an environmental assessment. An evaluation of potential effects of a proposed project on proposed, endangered, threatened, and sensitive animal and plant species and their habitats. (05 Dec 1998) |
|---|---|
| Brazelton's Neonatal Behavioural Assessment Scale | A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life. (05 Mar 2000) |
| geriatric assessment | Evaluation of the level of physical, physiological, or mental functioning in the older population group. (12 Dec 1998) |
| personality assessment | The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term. (12 Dec 1998) |
| risk assessment | The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (12 Dec 1998) |
| health risk assessment | Method of describing an individual's chance of falling ill or dying of a specified condition, based on actuarial calculations that allow for known exposure to risk; expressed as expected age at which death or disease will occur, and intended as a way of drawing an individual's attention to the probable consequences of risk behaviour. (05 Mar 2000) |
| process assessment | An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards. (12 Dec 1998) |
| prospective payment assessment commission | The commission charged with evaluating issues and factors which affect the implementation of the prospective payment system. (12 Dec 1998) |
| self assessment (psychology) | Appraisal of one's own personal qualities or traits. (12 Dec 1998) |
| subjective assessment data | Those facts that are observable and measurable by the nurse. (05 Mar 2000) |
| nursing assessment | Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning. (12 Dec 1998) |
| objective assessment data | Those facts presented by the client that show his/her perception, understanding and interpretation of what is happening. (05 Mar 2000) |
| outcome and process assessment | Evaluation procedures that focus on both the outcome or status (outcome assessment) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (process assessment) - what is done for the patient diagnostically and therapeutically. (12 Dec 1998) |
| outcome assessment | Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). (12 Dec 1998) |
| technology assessment, biomedical | Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. (12 Dec 1998) |